| ISIN | CH1284557100 |
|---|---|
| Valor Number | 128455710 |
| Bloomberg Global ID | ZKBAKCN SW |
| Fund Name | ZugerKB Fonds - Aktien ESG Schweiz (CHF) N |
| Fund Provider |
Zuger Kantonalbank AG, Zug
Baarerstrasse 37 6301 Zug Phone: +41 41 709 11 11 |
| Fund Provider | Zuger Kantonalbank AG, Zug |
| Representative in Switzerland | |
| Distributor(s) | Zuger Kantonalbank, Zug |
| Asset Class | Equities |
| EFC Category | Equity Switzerland |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | Das Anlageziel des Teilvermögens ZugerKB Fonds - Aktien Schweiz (CHF) besteht in einem langfristig möglichst hohen Anlageertrag in der Rechnungseinheit CHF. |
| Peculiarities |
| Current Price * | 127.27 CHF | 07.01.2026 |
|---|---|---|
| Previous Price * | 127.35 CHF | 06.01.2026 |
| 52 Week High * | 127.35 CHF | 06.01.2026 |
| 52 Week Low * | 105.23 CHF | 09.04.2025 |
| NAV * | 127.27 CHF | 07.01.2026 |
| Issue Price * | 127.27 CHF | 07.01.2026 |
| Redemption Price * | 127.27 CHF | 07.01.2026 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 256,324,780 | |
| Unit/Share Assets *** | 36,402,956 | |
| Trading Information SIX | ||
| YTD Performance | +0.75% |
31.12.2025 - 07.01.2026
31.12.2025 07.01.2026 |
|---|---|---|
| 1 month | +2.49% |
08.12.2025 - 07.01.2026
08.12.2025 07.01.2026 |
| 3 months | +5.57% |
07.10.2025 - 07.01.2026
07.10.2025 07.01.2026 |
| 6 months | +7.76% |
07.07.2025 - 07.01.2026
07.07.2025 07.01.2026 |
| 1 year | +10.09% |
07.01.2025 - 07.01.2026
07.01.2025 07.01.2026 |
| 2 years | +22.44% |
08.01.2024 - 07.01.2026
08.01.2024 07.01.2026 |
| 3 years | +32.51% |
01.11.2023 - 07.01.2026
01.11.2023 07.01.2026 |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UBS Group AG Registered Shares | 9.08% | |
|---|---|---|
| Roche Holding AG | 8.56% | |
| Nestle SA | 7.31% | |
| Novartis AG Registered Shares | 6.80% | |
| Lonza Group Ltd | 6.68% | |
| Zurich Insurance Group AG | 5.47% | |
| ABB Ltd | 4.90% | |
| Swiss Life Holding AG | 4.55% | |
| Compagnie Financiere Richemont SA Class A | 4.20% | |
| Swiss Re AG | 3.88% | |
| Last data update | 30.09.2025 | |
| TER | 0.10% |
|---|---|
| TER date | 31.05.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | |
| Ongoing Charges *** | 0.11% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |